News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,392 Results
Type
Article (70003)
Company Profile (221)
Press Release (637151)
Multimedia
Podcasts (102)
Webinars (20)
Section
Business (185635)
Career Advice (2807)
Deals (33331)
Drug Delivery (123)
Drug Development (83205)
Employer Resources (160)
FDA (17069)
Job Trends (14684)
News (327853)
Policy (32558)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (2920)
Academic (1)
Accelerated approval (40)
Adcomms (33)
Allergies (150)
Alliances (50798)
ALS (184)
Alzheimer's disease (1763)
Antibody-drug conjugate (ADC) (364)
Approvals (17293)
Artificial intelligence (574)
Autoimmune disease (173)
Automation (42)
Bankruptcy (341)
Best Places to Work (11371)
BIOSECURE Act (21)
Biosimilars (191)
Biotechnology (147)
Bladder cancer (172)
Brain cancer (67)
Breast cancer (692)
Cancer (5279)
Cardiovascular disease (421)
Career advice (2379)
Career pathing (42)
CAR-T (308)
CDC (58)
Celiac Disease (1)
Cell therapy (814)
Cervical cancer (39)
Clinical research (70699)
Collaboration (1858)
Company closure (4)
Compensation (771)
Complete response letters (75)
COVID-19 (2829)
CRISPR (101)
C-suite (897)
Cystic fibrosis (152)
Data (6449)
Decentralized trials (2)
Denatured (28)
Depression (149)
Diabetes (502)
Diagnostics (6742)
Digital health (45)
Diversity (11)
Diversity, equity & inclusion (40)
Drug discovery (282)
Drug pricing (188)
Drug shortages (25)
Duchenne muscular dystrophy (244)
Earnings (72497)
Editorial (65)
Employer branding (20)
Employer resources (146)
Events (98857)
Executive appointments (1011)
FDA (20340)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1556)
Gene editing (209)
Generative AI (56)
Gene therapy (640)
GLP-1 (1003)
Government (4633)
Grass and pollen (7)
Guidances (386)
Healthcare (18579)
HIV (68)
Huntington's disease (43)
IgA nephropathy (83)
Immunology and inflammation (251)
Immuno-oncology (73)
Indications (127)
Infectious disease (3122)
Inflammatory bowel disease (201)
Inflation Reduction Act (12)
Influenza (126)
Intellectual property (264)
Interviews (529)
IPO (15484)
IRA (49)
Job creations (3665)
Job search strategy (1953)
JPM (67)
Kidney cancer (19)
Labor market (76)
Layoffs (553)
Leadership (40)
Legal (7185)
Liver cancer (100)
Longevity (18)
Lung cancer (714)
Lymphoma (391)
Machine learning (47)
Management (55)
Manufacturing (809)
MASH (174)
Medical device (12667)
Medtech (12721)
Mergers & acquisitions (18902)
Metabolic disorders (1287)
mRNA (184)
Multiple sclerosis (174)
NASH (20)
Neurodegenerative disease (350)
Neuropsychiatric disorders (88)
Neuroscience (3074)
Neurotech (1)
NextGen: Class of 2026 (6390)
Non-profit (4841)
Now hiring (56)
Obesity (589)
Opinion (318)
Ovarian cancer (173)
Pain (212)
Pancreatic cancer (249)
Parkinson's disease (299)
Partnered (37)
Patents (521)
Patient recruitment (536)
Peanut (60)
People (56568)
Pharmaceutical (54)
Pharmacy benefit managers (30)
Phase 1 (22163)
Phase 2 (30886)
Phase 3 (23090)
Pipeline (5800)
Policy (302)
Postmarket research (2835)
Preclinical (9792)
Press Release (67)
Prostate cancer (270)
Psychedelics (53)
Radiopharmaceuticals (312)
Rare diseases (936)
Real estate (5789)
Recruiting (71)
Regulatory (25475)
Reports (38)
Research institute (2712)
Resumes & cover letters (448)
Rett syndrome (30)
RNA editing (16)
RSV (82)
Schizophrenia (156)
Series A (257)
Series B (195)
Service/supplier (10)
Sickle cell disease (103)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (46)
Startups (3553)
State (2)
Stomach cancer (21)
Supply chain (104)
Tariffs (75)
The Weekly (73)
Vaccines (1107)
Venture capital (94)
Weight loss (387)
Women's health (96)
Worklife (21)
Date
Today (111)
Last 7 days (824)
Last 30 days (2709)
Last 365 days (29424)
2026 (4703)
2025 (29751)
2024 (34317)
2023 (38910)
2022 (49769)
2021 (53907)
2020 (52451)
2019 (45666)
2018 (34789)
2017 (32479)
2016 (31851)
2015 (37162)
2014 (30043)
2013 (26663)
2012 (27572)
2011 (28243)
2010 (27056)
Location
Africa (952)
Alabama (91)
Alaska (6)
Arizona (260)
Arkansas (14)
Asia (43506)
Australia (7729)
California (10839)
Canada (3310)
China (1171)
Colorado (463)
Connecticut (491)
Delaware (308)
Europe (98999)
Florida (1645)
Georgia (335)
Hawaii (3)
Idaho (56)
Illinois (880)
India (72)
Indiana (509)
Iowa (21)
Japan (447)
Kansas (122)
Kentucky (40)
Louisiana (26)
Maine (80)
Maryland (1350)
Massachusetts (7743)
Michigan (324)
Minnesota (573)
Mississippi (5)
Missouri (135)
Montana (36)
Nebraska (28)
Nevada (121)
New Hampshire (76)
New Jersey (3027)
New Mexico (33)
New York (3062)
North Carolina (1438)
North Dakota (9)
Northern California (5257)
Ohio (338)
Oklahoma (21)
Oregon (45)
Pennsylvania (2141)
Puerto Rico (25)
Rhode Island (42)
South America (1237)
South Carolina (69)
South Dakota (1)
Southern California (4286)
Tennessee (167)
Texas (1753)
United States (39003)
Utah (333)
Vermont (1)
Virginia (269)
Washington D.C. (75)
Washington State (922)
West Virginia (3)
Wisconsin (122)
Wyoming (2)
707,392 Results for "ontario institute for cancer research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Itovebi® (inavolisib) marks milestone as the first breast cancer treatment funded through Ontario’s new faster access program
February 25, 2026
·
8 min read
Press Releases
FRUZAQLA(TM) (fruquintinib capsules) now reimbursed in Ontario to treat metastatic colorectal cancer (mCRC)
February 2, 2026
·
4 min read
Press Releases
Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
January 29, 2026
·
3 min read
Press Releases
Israel Cancer Research Fund and Cancer Research Institute Announce Co-Funding of Grant to Address Immunotherapy Resistance in Melanoma
January 23, 2026
·
3 min read
Press Releases
OPDIVO® Plus YERVOY® Reimbursed Under Ontario’s FAST Program as First-Line Treatment for Advanced Liver Cancer
February 3, 2026
·
4 min read
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
Press Releases
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
January 27, 2026
·
3 min read
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics
Providence Therapeutic Holdings Inc. and the Ontario Institute for Cancer Research, Ontario’s largest publicly funded cancer research institute delivering real-world solutions to people affected by cancer, announced the signing of a collaboration agreement for mRNA drug discovery and development.
May 23, 2024
·
3 min read
Press Releases
Florida Cancer Specialists & Research Institute Contributing To Breakthroughs In Treatment of Blood Cancers & Disorders
December 4, 2025
·
4 min read
Press Releases
Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer
December 22, 2025
·
5 min read
1 of 70,740
Next
